{"pmid":32434823,"title":"Rheumatic diseases in intensive care unit patients with COVID-19.","text":["Rheumatic diseases in intensive care unit patients with COVID-19.","Ann Rheum Dis","Moiseev, Sergey","Avdeev, Sergey","Brovko, Michail","Yavorovskiy, Andrey","Novikov, Pavel I","Umbetova, Karina","Akulkina, Larisa","Tsareva, Natal'ya","Fomin, Victor","32434823"],"journal":"Ann Rheum Dis","authors":["Moiseev, Sergey","Avdeev, Sergey","Brovko, Michail","Yavorovskiy, Andrey","Novikov, Pavel I","Umbetova, Karina","Akulkina, Larisa","Tsareva, Natal'ya","Fomin, Victor"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434823","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217676","keywords":["antirheumatic agents","autoimmune diseases","cytokines"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393624875009,"score":9.490897,"similar":[{"pmid":32295789,"title":"Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19.","text":["Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19.","Ann Rheum Dis","Lu, Chenyang","Li, Shasha","Liu, Yi","32295789"],"journal":"Ann Rheum Dis","authors":["Lu, Chenyang","Li, Shasha","Liu, Yi"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295789","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217460","keywords":["antirheumatic agents","cytokines","inflammation"],"topics":["Treatment"],"weight":1,"_version_":1666138493275865088,"score":76.34753},{"pmid":32299795,"title":"Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","text":["Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.","Ann Rheum Dis","Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas","32299795"],"journal":"Ann Rheum Dis","authors":["Gupta, Latika","Misra, Durga Prasanna","Agarwal, Vishwesh","Balan, Suma","Agarwal, Vikas"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299795","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217509","keywords":["antirheumatic agents","autoimmune diseases","biological therapy","communicable diseases, imported","glucocorticoids"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666138494849777664,"score":72.426155},{"pmid":32434818,"title":"Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.","text":["Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32434818"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434818","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217800","keywords":["antirheumatic agents","arthritis, rheumatoid","cardiovascular diseases"],"weight":0,"_version_":1667521393528406017,"score":64.584946},{"pmid":32341791,"pmcid":"PMC7174058","title":"Thoughts on COVID-19 and autoimmune diseases.","text":["Thoughts on COVID-19 and autoimmune diseases.","Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.","Lupus Sci Med","Askanase, Anca D","Khalili, Leila","Buyon, Jill P","32341791"],"abstract":["Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia."],"journal":"Lupus Sci Med","authors":["Askanase, Anca D","Khalili, Leila","Buyon, Jill P"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341791","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/lupus-2020-000396","keywords":["autoimmune diseases","cytokines","inflammation"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Chloroquine","tocilizumab","baricitinib"],"topics":["Treatment"],"weight":1,"_version_":1666138495775670272,"score":59.13472},{"pmid":32503855,"title":"Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak.","text":["Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak.","Ann Rheum Dis","Monti, Sara","Montecucco, Carlomaurizio","32503855"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Montecucco, Carlomaurizio"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503855","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/annrheumdis-2020-217957","keywords":["antirheumatic agents","cytokines","familial mediterranean fever"],"locations":["Kobak"],"e_drugs":["Colchicine"],"topics":["Treatment"],"weight":1,"_version_":1668892488174141440,"score":58.104656}]}